Association of triglyceride glucose index with cardiovascular autonomic neuropathy in type 2 diabetes mellitus - Report - MDSpire

Association of triglyceride glucose index with cardiovascular autonomic neuropathy in type 2 diabetes mellitus

  • By

  • Feijuan Kong

  • Ziqi Wang

  • Qiyu Yang

  • Jingzhu Wu

  • Shanshan Tang

  • Mingyu Gu

  • Xiaoying Ding

  • Yufan Wang

  • July 9, 2026

  • 0 min

Share

Clinical Report: Relationship Between Triglyceride-Glucose Index and Cardiovascular Autonomic Neuropathy in Patients with Type 2 Diabetes Mellitus

Overview

This study investigates the association between the triglyceride-glucose (TyG) index and cardiovascular autonomic neuropathy (CAN) in patients with type 2 diabetes mellitus (T2DM). It finds that a higher TyG index correlates with increased prevalence of CAN.

Background

Cardiovascular autonomic neuropathy (CAN) is a common yet often underdiagnosed complication of diabetes, linked to increased cardiovascular risk. The triglyceride-glucose (TyG) index is a marker of insulin resistance.

Data Highlights

ParameterValue
Prevalence of CAN61.3%
AUC for TyG index0.854 (95% CI: 0.796–0.911)

Key Findings

  • The prevalence of CAN in the study cohort was 61.3%.
  • Patients with CAN had a significantly higher TyG index compared to those without CAN.
  • The TyG index positively correlated with CART parameters, including E:I difference and Valsalva ratio.
  • Inverse correlations were found between the TyG index and various HRV indices, indicating reduced heart rate variability.
  • After adjusting for confounders, the TyG index remained a significant independent predictor of CAN.
  • ROC curve analysis indicated favorable discriminatory power of the TyG index for CAN.

Clinical Implications

The findings indicate a relationship between the TyG index and CAN.

Conclusion

The study highlights the association between the TyG index and cardiovascular autonomic neuropathy.

Related Resources & Content

  1. Frontiers in Endocrinology, 2026 -- Triglyceride–glucose related index and its association with coronary heart disease risk in patients with metabolic dysfunction-associated steatotic liver disease
  2. Frontiers in Endocrinology, 2026 -- Association between triglyceride glucose-body mass index and incident risk of heart failure among patients with type 2 diabetes
  3. Frontiers in Cardiovascular Medicine, 2026 -- Unveiling a J-shaped association between the triglyceride-glucose index and in-hospital major adverse cardiovascular events in patients with acute myocardial infarction
  4. PMC, 2026 -- Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2026
  5. BMJ, 2023 -- Cardiac autonomic neuropathy and risk of cardiovascular disease and mortality in type 1 and type 2 diabetes: a meta-analysis
  6. Frontiers in Endocrinology — Linking Serum Neutrophil Extracellular Traps to Carotid Intima-Media Thickness in Individuals with Type 2 Diabetes: A Cross-Sectional Analysis
  7. 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2026 - PMC
  8. Cardiac autonomic neuropathy and risk of cardiovascular disease and mortality in type 1 and type 2 diabetes: a meta-analysis
  9. Triglyceride–glucose index and the risk of in-hospital and ICU all-cause mortality: a systematic review and meta-analysis of observational studies | Nutrition & Diabetes

Original Source(s)

Related Content